<DOC>
	<DOC>NCT01635959</DOC>
	<brief_summary>The purpose of this study is to calculate the prevalence of gastroesophageal reflux disease (GERD) by mean of GERD-Q questionnaire in patients with upper gastrointestinal tract symptoms in Egypt.</brief_summary>
	<brief_title>Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt</brief_title>
	<detailed_description>Prevalence of Gastroesophageal reflux disease (GERD) in patients with upper gastrointestinal tract symptoms in Egypt</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<criteria>18 years and above Attending the medical office and reporting symptoms suggestive of upper gastrointestinal tract symptoms such as heartburn/regurgitation, abdominal pain, bloating, belching and nausea/vomiting. Participating on a clinical trial during the last 3 months. Patients not able to read and/or understand the GERDQ questionnaire. Patients already included in the study in other participating site. Patients taking PPIs or H2blockers in the l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>upper gastro-intestinal symptoms, GERD</keyword>
</DOC>